<?xml version='1.0' encoding='utf-8'?>
<document id="22767428"><sentence text="Investigation of the in vitro metabolism of evodiamine: characterization of metabolites and involved cytochrome p450 isoforms."><entity charOffset="44-54" id="DDI-PubMed.22767428.s1.e0" text="evodiamine" /></sentence><sentence text="Evodiamine is the main active alkaloid of Evodia rutaecarpa (E"><entity charOffset="0-10" id="DDI-PubMed.22767428.s2.e0" text="Evodiamine" /><entity charOffset="30-38" id="DDI-PubMed.22767428.s2.e1" text="alkaloid" /><pair ddi="false" e1="DDI-PubMed.22767428.s2.e0" e2="DDI-PubMed.22767428.s2.e0" /><pair ddi="false" e1="DDI-PubMed.22767428.s2.e0" e2="DDI-PubMed.22767428.s2.e1" /></sentence><sentence text=" rutaecarpa) and has been demonstrated to exhibit many pharmacological activities including vasorelaxation, uterotonic action, anoxia and control of body temperature" /><sentence text=" The present study focused on the metabolism of evodiamine"><entity charOffset="48-58" id="DDI-PubMed.22767428.s4.e0" text="evodiamine" /></sentence><sentence text=" Human and phenobarbital-induced rat liver microsomal incubation of evodiamine in the presence of NADPH resulted in the formation of five major metabolites (M-1, M-2, M-3, M-4, M-5)"><entity charOffset="68-78" id="DDI-PubMed.22767428.s5.e0" text="evodiamine" /><entity charOffset="98-103" id="DDI-PubMed.22767428.s5.e1" text="NADPH" /><pair ddi="false" e1="DDI-PubMed.22767428.s5.e0" e2="DDI-PubMed.22767428.s5.e0" /><pair ddi="false" e1="DDI-PubMed.22767428.s5.e0" e2="DDI-PubMed.22767428.s5.e1" /></sentence><sentence text=" Four metabolites (M-1, M-2, M-3 and M-5) were identified to mono-hydroxylated evodiamine and one metabolite (M-4) was identified to be N-demethylated evodiamine"><entity charOffset="151-161" id="DDI-PubMed.22767428.s6.e0" text="evodiamine" /></sentence><sentence text=" CYP3A4, CYP2C9 and CYP1A2 were identified to be the main CYP isoforms involved in the metabolism of evodiamine in human liver microsomes"><entity charOffset="101-111" id="DDI-PubMed.22767428.s7.e0" text="evodiamine" /></sentence><sentence text=" Finding new metabolites can help us decipher novel substance basis of efficiency and toxicity" /><sentence text=" Elucidation of drug metabolizing enzymes will facilitate explaining the individual difference for response to the same drugs or herbs and the potential drug-drug interaction or herb-drug interaction" /><sentence text=" Taken together, these results are of significance for better understanding the pharmacokinetic behaviour of evodiamine and helpful for clinical application of evodiamine and E"><entity charOffset="109-119" id="DDI-PubMed.22767428.s10.e0" text="evodiamine" /><entity charOffset="160-170" id="DDI-PubMed.22767428.s10.e1" text="evodiamine" /><pair ddi="false" e1="DDI-PubMed.22767428.s10.e0" e2="DDI-PubMed.22767428.s10.e0" /><pair ddi="false" e1="DDI-PubMed.22767428.s10.e0" e2="DDI-PubMed.22767428.s10.e1" /></sentence><sentence text=" rutaecarpa" /><sentence text="" /></document>